Barceló Solymar
Grupo Hotelero Islazul
blackanddecker
AVA Resorts
MAD-HAV Enjoy Travel Group
Realidad Turística
Intecap
Walmart
INOR
MITM Events
Cervecería Centroamericana S.A.
Herbalife
Centro Nacional de Cirugía de Mínimo Acceso de Cuba
Instituto Hondureño de Turismo
Nestle
Servicios Médicos Cubanos
INTERFER
MuniGuate
Cubasol
Los Portales
CUN-HAV Enjoy Travel Group
Agexport

Health Secretary Shares Concerns About Efficacy of Novavax COVID-19 Vaccine After FDA Delay

Date:

Share:

INTERFER
Nestle
Grupo Hotelero Islazul
Realidad Turística
Los Portales
INOR
Centro Nacional de Cirugía de Mínimo Acceso de Cuba
AVA Resorts
Herbalife
Instituto Hondureño de Turismo
Intecap
blackanddecker
Cervecería Centroamericana S.A.
MITM Events
Servicios Médicos Cubanos

Estimated reading time: 3 minutes

Health Secretary Robert F. Kennedy Jr. said in a new interview that Novavax’s COVID-19 vaccine is not effective, his first comments since regulators missed a deadline to approve the shot.

“We’re looking at that vaccine. It is a single antigen vaccine, and for respiratory illnesses, the single antigen vaccines have never worked,” Kennedy told CBS in an interview released on April 9.

The Food and Drug Administration (FDA) was supposed to decide whether to grant Novavax’s license application by April 2, the Maryland-based company has said. The firm makes one of the three COVID-19 vaccines available in the United States, and the only one that does not use messenger ribonucleic acid technology.

The FDA has not said why the deadline passed without a decision.

An official with the Department of Health and Human Services (HHS), which Kennedy heads, previously told The Epoch Times in an email that “any delays to the FDA’s independent review process for the Novavax are a result of scientific review to ensure safety and efficacy.” The FDA is part of HHS.

Kennedy was asked in the new interview if the delay stemmed from a lack of personnel, after the departure of Dr. Peter Marks, among others. Marks led the FDA’s office in charge of reviewing vaccines.

“We are actually shifting our priorities to multiple antigen vaccines. And NIH is already working on a number of those,” Kennedy said, referring to another HHS division, the National Institutes of Health.

In an April 10 statement, Novavax said, “As we have previously stated, we believe that our Biologics License Application (BLA) for our COVID-19 vaccine included robust Phase 3 clinical trial data that showed our vaccine is safe and effective for the prevention of COVID-19.”

It pointed to a clinical trial conducted by the company that recorded 14 cases of COVID-19 among vaccine recipients and 63 cases among recipients of a placebo, as well as a second trial that found the efficacy of the vaccine was 79.5 percent among adolescents.

“We have not yet received an official response from the U.S. Food and Drug Administration regarding the status of our BLA,” the company said.

The other two COVID-19 vaccines that are cleared by the FDA are made by Moderna and Pfizer. Both are built on messenger ribonucleic acid technology, or mRNA, platforms.

The FDA in 2024, in its most recent action on the vaccines, cleared updated COVID-19 vaccines from all three manufacturers, stating that older versions were not as effective against newer COVID-19 strains. Novavax’s updated shot received emergency authorization, as opposed to approval.

Novavax shares dropped from $6.95 on April 9 to $5.12 on April 10, though the price had partially rebounded to $5.61 on Friday.

Theepochtimes.com

Grupo Hotelero Islazul
Nestle
Realidad Turística
MITM Events
Los Portales
AVA Resorts
INOR
Instituto Hondureño de Turismo
Walmart
blackanddecker
Barceló Solymar
MuniGuate
Intecap
MAD-HAV Enjoy Travel Group
Agexport
Herbalife
Centro Nacional de Cirugía de Mínimo Acceso de Cuba
Servicios Médicos Cubanos
INTERFER
CUN-HAV Enjoy Travel Group
Cervecería Centroamericana S.A.
Cubasol
MuniGuate
AirEuropa
Revista Colombiana de Turismo Passport
INTERFER
Maggi - GLUTEN-FREE
Hotel Barcelo Solymar
Henkel Latinoamerica
Hotel Holiday Inn Guatemala
Havanatur
Intecap
Cubacel
Blue Diamond Resorts
Barcelo Guatemala City

Subscribe to our magazine

━ more like this

Pole Dancing in Israel: A New Dimension with BlueDance.co.il

In recent years, pole dancing has experienced a remarkable transformation, shifting from a misunderstood niche to a popular activity combining fitness, self-expression, and empowerment....

A New Luxury Hotel Just Opened on An Idyllic Beach in Cancun, Mexico — And We Were the First to Stay

Waldorf Astoria Cancun opened to the public on Nov. 1, the brand's first new build in Mexico, with two waterfront pools and a fantastic...

Pan American Health Organization Launches Interactive Dashboard on Avian Influenza in The Americas

To monitor cases of avian influenza A (H5N1) in the Americas, the Pan American Health Organization (PAHO) launched an interactive dashboard on the web...

Nicaragua Presents Its New Interoceanic Canal Route to China and Seeks to Compete with Panama

Estimated reading time: 8 minutes With a length of 445 kilometers, in a second attempt, the Nicaraguan president, Daniel Ortega, presents China with a new...

US Lawmakers Join Requests to Extend TPS To Central Americans

The chairman of the US Senate Foreign Relations Committee, Robert Menendez, along with other legislators gathered outside the Capitol this Thursday to express his...
INTERFER
Havanatur
Cubacel
Hotel Holiday Inn Guatemala
Blue Diamond Resorts
Revista Colombiana de Turismo Passport
Maggi - GLUTEN-FREE
Henkel Latinoamerica
AirEuropa
Intecap
Barcelo Guatemala City
Hotel Barcelo Solymar

LEAVE A REPLY

Please enter your comment!
Please enter your name here

INTERFER
MITM Events
Instituto Hondureño de Turismo
Nestle
Intecap
Los Portales
Cubasol
MuniGuate
Herbalife
MAD-HAV Enjoy Travel Group
Barceló Solymar
Grupo Hotelero Islazul
AVA Resorts
Walmart
Centro Nacional de Cirugía de Mínimo Acceso de Cuba
blackanddecker
Servicios Médicos Cubanos
Agexport
Realidad Turística
INOR
Cervecería Centroamericana S.A.